Shiseido IBUKI Multi Solution Gel
Natural health product licensed in Canada
- Licence holder
- Shiseido America Inc.
- NPN or DIN-HM
- 80052074
- Status
- Inactive licence
- Licence date
- 24 June 2014
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 2-hydroxybenzoïque | 0.5 % |
Non-medicinal ingredients
Glycérine, Parfum, Chlorure de sodium, Stérol de soja de PEG-30, Lécithine hydrogénée, Jaune FD&C No. 5, L-Sérine, Diméthicone, SD alcool 40-B, PEG-240/HDI copolymère de bis-décyltetradéceth-20 éther, EDTA de sodium, Butylène glycol, Eau, PEG/PPG-14/7 diméthyl éther, Gomme de gellane, Hydroxytoluène butylé, Acide citrique, Dipeptide-15, Silice, Extrait de graine d'Aesculus Hippocastanum (marronnier d'Inde), Alcool, Glycyrrhizate de dipotassium, Extrait de racine de Paeonia Suffruticosa, Phénoxyéthanol, Polymère croisé d'acrylates/acrylate d'alkyle en C10 à 30, Citrate de sodium, Huile de ricin hydrogénée de PEG-60, Hydroxyde de potassium, EDTA trisodium, Trehalose, Bleu 1, Poly(quaternium-51)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Gel | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps treat acne pimples.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80052074
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.